Anti-Mycobacterium tuberculosis vaccine using sendai virus as vector
US10828359B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 19, 2016 |
| Grant date | Nov 10, 2020 |
| Priority date | — |
| Expiry date | Sep 1, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18843
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided in the present application are a recombinant sendai virus vector vaccine expressing immunodominant antigens of Mycobacterium tuberculosis, and can be used as therapeutic and preventive antituberculosis vaccine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.